Ligand validation:3LN0

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3LN0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LN0_NAG_A_681	30%	46%	0.184	0.849	0.72	1.35	-	3	0	0	100%	0.9333
3LN0_NAG_D_681	26%	50%	0.212	0.854	0.6	1.32	-	3	0	0	100%	0.9333
3LN0_NAG_C_681	16%	56%	0.242	0.811	0.62	1.08	-	1	0	0	100%	0.9333
3LN0_NAG_B_681	15%	48%	0.271	0.835	0.6	1.37	-	2	0	0	100%	0.9333
3LN0_NAG_D_661	9%	59%	0.295	0.785	0.34	1.21	-	2	2	0	100%	0.9333
3LN0_NAG_A_661	8%	56%	0.302	0.776	0.42	1.26	-	1	1	0	100%	0.9333
3LN0_NAG_C_661	8%	51%	0.301	0.767	0.56	1.31	-	1	2	0	100%	0.9333
3LN0_NAG_B_661	6%	49%	0.289	0.728	0.57	1.36	-	4	1	0	100%	0.9333
6OFY_NAG_B_602	88%	26%	0.085	0.962	1.43	1.55	2	6	0	0	100%	0.9333
3RR3_NAG_B_671	83%	48%	0.081	0.951	0.68	1.31	-	2	4	0	93%	0.9333
6BL4_NAG_C_705	80%	83%	0.107	0.957	0.32	0.46	-	-	0	0	100%	0.9333
3Q7D_NAG_B_671	70%	40%	0.112	0.942	0.8	1.53	1	4	5	0	93%	0.9333
4Z0L_NAG_D_705	70%	90%	0.123	0.94	0.2	0.4	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.